A neurologist grapples with aducanumab
I have been following the controversy surrounding the approval of the new Alzheimer’s drug aducanumab with great interest. Until a year and a half ago, I worked as a neurologist in an adult general neurology clinic. Many of my patients had dementia. While I thoroughly enjoyed seeing these patients and their family members, I often felt helpless when treating them. When I left clinical practice to explore a non-clinical career …







![Waking up at 4 a.m. is not required for success [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-3-190x100.jpg)


![Primary care offers unexpected financial and emotional wealth [PODCAST]](https://kevinmd.com/wp-content/uploads/Design-2-190x100.jpg)
